The global digital pathology market size was valued at USD 1.47 billion in 2025 and is projected to grow from USD 1.59 billion in 2026 to USD 3.05 billion by 2034, registering a CAGR of 8.43% during the forecast period from 2026 to 2034. North America dominated the digital pathology market with a market share of 41.6% in 2025.
Digital pathology refers to the acquisition, management, analysis, storage, and interpretation of pathology information using digitized glass slides, whole slide imaging scanners, image management software, artificial intelligence algorithms, cloud-based platforms, and digital workflow tools.
The digital pathology market demand is driven by the rising need for faster diagnoses, increasing cancer burden, shortage of trained pathologists, and growing transition from conventional microscope-based pathology to whole slide imaging-based diagnostic workflows.
Download a Free Sample To learn more about this report,
Increasing Adoption of Whole-Slide Imaging for Digital Diagnostic Workflows
The digital pathology market is increasingly shifting from conventional microscope-based workflows toward whole-slide imaging systems that convert tissue slides into high-resolution digital images. Whole-slide imaging enables pathologists to access, store, share, and review pathology cases digitally, while supporting remote consultation, workflow standardization, and integration with image analysis technologies.
Growing Integration of Artificial Intelligence and Computational Image Analysis in Pathology
Artificial intelligence and computational image analysis are becoming increasingly integrated into digital pathology platforms to support tumor detection, tissue classification, biomarker quantification, and diagnostic workflow optimization. AI-assisted analysis can help pathologists manage growing workloads, improve quantitative assessment, and extract additional insights from high-resolution pathology images.
Rising Cancer Burden and Pathologist Workforce Shortages Support Digital Pathology Adoption
The growing volume of cancer diagnostics and increasing pressure on pathology workforces are strengthening demand for digital workflows that improve access to specialist expertise and support efficient case management. Digital pathology enables remote slide review, collaborative consultation, workload distribution, and AI-assisted analysis, helping healthcare organizations manage increasing diagnostic requirements.
High Infrastructure and Data Management Costs Can Limit Digital Pathology Adoption
Digital pathology implementation requires investment in whole-slide scanners, high-capacity storage, image management software, network infrastructure, cybersecurity, and system integration. The large size of high-resolution pathology images can further increase storage and data-management requirements, creating financial and technical barriers for laboratories with limited resources.
Expansion of Cloud-Based Pathology and Remote Consultation Creates New Growth Opportunities
The expansion of cloud-enabled pathology platforms and remote consultation services is creating opportunities to connect pathologists across healthcare networks and geographic regions. Cloud-based systems can facilitate centralized image access, specialist collaboration, distributed diagnostics, and scalable data management while supporting healthcare organizations with limited local pathology expertise.
Interoperability and Standardization Across Digital Pathology Platforms Create Challenges
Digital pathology workflows must connect scanners, image management systems, laboratory information systems, AI algorithms, and other healthcare technologies while maintaining compatible image formats and consistent data structures. Differences in platform architecture, third-party algorithm compatibility, regulatory requirements, and technical infrastructure can complicate implementation and limit flexibility when laboratories scale digital pathology programs.
Software Segment is Projected to Register the Fastest Growth at a CAGR of 10.4%
The software segment is projected to register the fastest growth at a CAGR of 10.4% during 2026–2034. In 2025, the segment accounted for 37.5% of the global digital pathology market, with a value of USD 0.55 billion. Growth is driven by increasing adoption of artificial intelligence, cloud-based pathology platforms, and advanced image analysis solutions that improve diagnostic accuracy and laboratory workflow efficiency. Rising investments in digital healthcare infrastructure and precision diagnostics are expected to further support the segment's growth.
The device segment dominated the market owing to the growing deployment of digital pathology hardware across hospitals, research laboratories, and diagnostic centers. Within this category, scanners accounted for the largest share due to their critical role in converting glass slides into high-resolution digital images for diagnosis and analysis. Slide management systems continue to witness steady demand by improving workflow organization and case management, while storage systems are gaining traction as healthcare organizations require secure and scalable solutions to manage the growing volume of digital pathology images.
Request Customizationto receive a tailored report.
Human Pathology Segment Dominated the Market with 91.3% Share in 2025
The human pathology segment dominated the global digital pathology market with a 91.3% share in 2025, representing a market value of USD 1.34 billion. The segment is projected to grow at a CAGR of 9.4% during 2026–2034. Its dominance is driven by the increasing prevalence of chronic diseases, rising cancer diagnosis rates, and widespread adoption of digital pathology solutions for clinical diagnostics, disease monitoring, and precision medicine. Continuous advancements in pathology imaging technologies continue to strengthen the segment's market position.
The veterinary pathology segment continues to witness steady growth owing to increasing awareness of animal healthcare, growing demand for advanced diagnostic services in veterinary medicine, and expanding research activities involving animal diseases and pathology.
Drug Discovery & Development Segment is Projected to Register the Fastest Growth at a CAGR of 9.8%
The drug discovery & development segment is projected to register the fastest growth at a CAGR of 9.8% during 2026–2034. In 2025, the segment accounted for 29.4% of the global digital pathology market, with a value of USD 0.43 billion. Growth is driven by increasing pharmaceutical research, rising adoption of digital imaging technologies in preclinical studies, and growing demand for efficient pathology workflows during drug development. Expanding investments in precision medicine and biomarker research are expected to further support the segment's growth.
The disease diagnosis segment dominated the market owing to the increasing use of digital pathology for accurate disease detection, cancer diagnosis, and clinical decision-making across healthcare facilities. The academic research segment continues to witness steady demand as universities and research organizations increasingly utilize digital pathology platforms for pathology education, biomedical research, and collaborative studies.
The others segment includes forensic pathology, veterinary research, and specialized pathology applications that continue to benefit from advancements in digital imaging, data management, and artificial intelligence technologies.
Biotech & Pharma Companies Segment is Projected to Register the Fastest Growth at a CAGR of 9.9%
The biotech & pharma companies segment is projected to register the fastest growth at a CAGR of 9.9% during 2026–2034. In 2025, the segment accounted for 25.6% of the global digital pathology market, with a value of USD 0.38 billion. Growth is driven by increasing investments in drug discovery, biomarker identification, and clinical research, along with growing adoption of digital pathology platforms to accelerate research and development activities. Continued advancements in artificial intelligence-assisted pathology are expected to further strengthen the segment's growth.
The hospitals segment dominated the market owing to the increasing adoption of digital pathology systems for routine diagnostics, improved laboratory efficiency, and enhanced collaboration among pathologists. The diagnostic labs segment continues to witness strong demand as laboratories increasingly digitize pathology workflows to improve diagnostic accuracy, reduce turnaround times, and support remote pathology services.
The academic & research institutes segment continues to maintain steady growth due to expanding biomedical research activities, pathology education programs, and collaborative research initiatives that rely on advanced digital pathology technologies.
Speak to an Analystto discuss market opportunities.
North America digital pathology market accounted for 41.6% of the global market, reaching USD 0.61 billion in 2025, and is projected to grow at a CAGR of 8.7% during the forecast period. The market is driven by increasing adoption of digital imaging technologies, rising demand for AI-assisted pathology workflows, expanding prevalence of cancer, and strong healthcare infrastructure. Growing investments in precision medicine and laboratory digitization continue to support regional market growth.
The US market was valued at USD 0.52 billion in 2025, making it the largest contributor in North America. Rising adoption of whole-slide imaging systems, increasing demand for AI-powered diagnostic tools, expanding digital laboratory transformation, and continuous investments in pathology research continue to drive market growth.
Canada's market reached USD 0.09 billion in 2025. Growing healthcare investments, increasing implementation of digital pathology platforms, expanding telepathology services, and rising demand for efficient diagnostic workflows continue to support steady market expansion.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe digital pathology market accounted for 27.4% of the global market, reaching USD 0.40 billion in 2025, and is projected to grow at a CAGR of 8.9% during the forecast period. Increasing adoption of digital diagnostics, expanding investments in healthcare modernization, rising use of AI-enabled pathology solutions, and supportive regulatory initiatives continue to strengthen regional market growth. Ongoing research in precision medicine further supports market expansion.
The UK market was valued at USD 0.08 billion in 2025. Growing implementation of digital pathology systems, increasing investments in healthcare digitization, expanding cancer screening programs, and rising adoption of remote pathology services continue to support market growth.
Germany market accounted for USD 0.11 billion in 2025. Strong diagnostic infrastructure, increasing adoption of digital imaging technologies, expanding laboratory automation, and growing investments in AI-based pathology solutions continue to drive market expansion.
Asia Pacific digital pathology market accounted for 21.8% of the global market, reaching USD 0.32 billion in 2025, and is projected to grow at a CAGR of 11.6% during the forecast period. Rising healthcare expenditure, increasing prevalence of chronic diseases, expanding pathology laboratory infrastructure, and growing adoption of digital healthcare technologies continue to accelerate regional market growth. Government initiatives supporting healthcare digitalization further strengthen market expansion.
Japan's market generated USD 0.06 billion in 2025. Increasing adoption of AI-assisted pathology platforms, expanding precision medicine initiatives, growing healthcare innovation, and rising demand for advanced diagnostic technologies continue to support market growth.
China's market accounted for USD 0.13 billion in 2025, representing the largest share within Asia Pacific. Expanding healthcare infrastructure, increasing laboratory digitization, growing investments in artificial intelligence, and rising demand for accurate pathology diagnostics continue to drive market expansion.
Latin America digital pathology market accounted for 5.1% of the global market, reaching USD 0.07 billion in 2025, and is projected to grow at a CAGR of 8.4% during the forecast period. Increasing investments in healthcare infrastructure, expanding access to advanced diagnostic technologies, growing awareness of digital pathology solutions, and rising demand for efficient laboratory workflows continue to support regional market growth.
Brazil market accounted for USD 0.04 billion in 2025. Rising adoption of digital pathology systems, increasing healthcare modernization initiatives, expanding diagnostic laboratory capabilities, and growing investments in precision diagnostics continue to support market expansion.
Middle East & Africa digital pathology market accounted for 4.1% of the global market, totaling USD 0.06 billion in 2025, and is projected to grow at a CAGR of 7.9% during the forecast period. Increasing investments in healthcare infrastructure, expanding adoption of digital diagnostic technologies, growing laboratory modernization initiatives, and rising awareness of precision medicine continue to support regional market growth.
The UAE market was valued at USD 0.01 billion in 2025. Increasing investments in advanced healthcare facilities, expanding implementation of digital pathology platforms, growing healthcare digitization, and rising demand for AI-enabled diagnostics continue to drive market growth.
Africa's market reached USD 0.05 billion in 2025. Improving healthcare infrastructure, increasing access to digital diagnostic technologies, expanding pathology laboratory capabilities, and growing investments in healthcare modernization continue to create long-term growth opportunities across the region.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Ablation Technology Market Size, Share, Growth, Analysis, 2034
Clinical Data Analytics Solutions Market Size, Share, Growth, 2034
Operating Room Integration Market Size, Share, Growth, 2034
Telepsychiatry Market Size, Share, Growth, Analysis, Report, 2034
Healthcare Cloud Infrastructure Market Size, Share, Growth, 2034
Population Health Management Market Size, Share, 2034
We are featured on:
sales@straitsresearch.com